BIENAIME JEAN JACQUES

BMRN

BIENAIME JEAN JACQUES serves as director at BioMarin Pharmaceutical Inc. (BMRN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

12 trades

$696.1K

Total Sells

42 trades

$77.84M

Net Position

Net Seller

$77.15M

Companies Traded

KROS, IMNM, BMRN

Active Period

Feb 2021 – Jun 2026

54 total trades

Most Recent

Buy KROS

Jun 17, 2026 · $10.2K

BIENAIME JEAN JACQUES's Insider Trading at BioMarin Pharmaceutical Inc. (BMRN)

Buys

0 · $0.00

Sells

4 · $4.38M

Total Shares Bought

Total Shares Sold

55,604

BMRN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 22, 2021	Sell	5,519	$78.52	$433.4K
Mar 15, 2021	Sell	28,985	$78.16	$2.27M
Mar 4, 2021	Sell	14,100	$77.39	$1.09M
Feb 19, 2021	Sell	7,000	$83.58	$585.1K

Showing 51–54 of 54

Related Insiders

Kinney Horn

officer: CHIEF BUSINESS OFFICER

IMNMSell · Jul 9, 2026

Isaac Barchas

Director

IMNMSell · Jul 7, 2026

Robert Lechleider

officer: Chief Medical Officer

IMNMSell · Jul 7, 2026

Max Rosett

officer: Chief Financial Officer

IMNMSell · Jun 17, 2026

Charles W. Newton

director

KROSSell · Jun 15, 2026

Nima Farzan

director

KROSSell · Jun 8, 2026

Julius Knowles

director

KROSSell · Jun 8, 2026

Seth Alpna

director

KROSSell · Jun 5, 2026

Explore More Insider Trading Data

BMRN Insider Trading Activity

View all insider trades at BioMarin Pharmaceutical Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity